DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface

Abstract

The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.

Inventors:
;
Issue Date:
Research Org.:
University of Georgia, Athens, GA (Unites States); Abeome Corporation, Athens, GA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1176025
Patent Number(s):
7148040
Application Number:
10/079,130
Assignee:
University of Georgia Research Foundation, Inc. (Athens, GA) ; Abeome Corporation (Athens, GA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
FG07-96ER20257
Resource Type:
Patent
Resource Relation:
Patent File Date: 2002 Feb 20
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Meagher, Richard B., and Laterza, Vince. Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface. United States: N. p., 2006. Web.
Meagher, Richard B., & Laterza, Vince. Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface. United States.
Meagher, Richard B., and Laterza, Vince. Tue . "Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface". United States. https://www.osti.gov/servlets/purl/1176025.
@article{osti_1176025,
title = {Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface},
author = {Meagher, Richard B. and Laterza, Vince},
abstractNote = {The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Dec 12 00:00:00 EST 2006},
month = {Tue Dec 12 00:00:00 EST 2006}
}

Works referenced in this record:

Molecular cloning of the Ig-? subunit of the human B-cell antigen receptor complex
journal, July 1992


Transcriptional and posttranscriptional control of immunoglobulin mRNA production during Blymphocyte development
journal, January 1986


B Cell Development Is Arrested at the Immature B Cell Stage in Mice Carrying a Mutation in the Cytoplasmic Domain of Immunoglobulin β
journal, December 2000


Clinical trials of antibody therapy
journal, August 2000


Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
journal, March 1982


Signal Transduction by the Antigen Receptors of B and T Lymphocytes
book, January 1995


The metabolism of a poly(A) minus mRNA fraction in HeLa cells
journal, September 1974


Optimizing antibody production in batch hybridoma cell culture
journal, May 1995


The B-cell antigen receptor complex
journal, June 1991


A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization
journal, December 1998


B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties.
journal, November 1988


Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR Complex
journal, June 1996


Igα: B all that you can B
journal, October 1999


B Cell Progenitors Are Arrested in Maturation but Have Intact VDJ Recombination in the Absence of Ig-α and Ig-β
journal, July 2002


An unsolved problem of the clonal selection theory and the model of an oligomeric B-cell antigen receptor
journal, August 2000


Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion
journal, July 1976


Ig-α Cytoplasmic Truncation Renders Immature B Cells More Sensitive to Antigen Contact
journal, November 1999


Antigen Receptors on B Lymphocytes
journal, April 1992


Immunoglobulin gene expression in transformed lymphoid cells.
journal, February 1983


Changes in abundance of IgG 2a mRNA in the nucleus and cytoplasm of a murine B-lymphoma before and after fusion to a myeloma cell
journal, May 1996


Identification of the genes encoding the IgM-α and Ig-β components of the IgM antigen receptor complex by amino-terminal sequencing
journal, December 1990


Increased half-life of μ immunoglobulin mRNA during mouse B cell development increases its abundancy
journal, August 1990


Alternative poly(A) site selection in complex transcription units: means to an end?
journal, July 1997


Differential mRNA stabilities affect mRNA levels in mutant mouse myeloma cells
journal, January 1991


Analysis of receptor signaling pathways by mass spectrometry: Identification of Vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors
journal, January 2000


Monoclonal antibodies to beta-adrenergic receptors: use in purification and molecular characterization of beta receptors.
journal, December 1980


Scaffolds for engineering novel binding sites in proteins
journal, August 1997


50 million years of chordate evolution: Seeking the origins of adaptive immunity
journal, June 2000


Alternative splicing of CD79a (Ig-αmb-1) and CD79b (Ig-βB29) RNA transcripts in human B cells
journal, June 1995


Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975


Printing Proteins as Microarrays for High-Throughput Function Determination
journal, September 2000


Molecular components of the B-cell antigen receptor complex of the IgM class
journal, February 1990


Differential signaling through the Ig-α and Ig-β components of the B cell antigen receptor
journal, April 1993


Rapid Isolation of Monoclonal Antibodies. Monitoring Enzymes in the Phytochelatin Synthesis Pathway
journal, November 2001


Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
journal, November 1998


The cytoplasmic domains of immunoglobulin (Ig) alpha and Ig beta can independently induce the precursor B cell transition and allelic exclusion.
journal, November 1995


Use of Monoclonal Antibodies for the Diagnosis and Treatment of Bladder Cancer
journal, June 1999


Rapid Hybridoma Screening Method for the Identification of Monoclonal Antibodies to Low-Abundance Cytoplasmic Proteins
journal, November 1998


Aberrant Trafficking of the B Cell Receptor Ig-αβ Subunit in a B Lymphoma Cell Line
journal, August 2000


Transcriptional regulation of the mu-delta heavy chain locus in normal murine B lymphocytes.
journal, August 1984


Genomic Instability and Telomerase Activity in Human Bronchial Epithelial Cells during Immortalization by Human Papillomavirus-16 E6 and E7 Genes
journal, August 1997


The hybridoma revolution: an offshoot of basic research
journal, October 1999


Monoclonal antibodies to human estrogen receptor.
journal, September 1980


With the benefit of hindsight
journal, August 2000


Stability of the B cell antigen receptor complex
journal, April 2000


Immortalization of human embryonic fibroblasts by overexpression of c-myc and simian virus 40 large T antigen
journal, December 2001


Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.
journal, April 1979


Genomics, gene expression and DNA arrays
journal, June 2000


Renaissance of cancer therapeutic antibodies
journal, June 2003


Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism
journal, September 2001


Proteomics
journal, April 1998


Structure and Function of the B-Cell Antigen Receptor
book, January 1994


The late pollen-specific actins in angiosperms
journal, June 1999


The 3′-Untranslated Region of Membrane Exon 2 from the γ2a Immunoglobulin Gene Contributes to Efficient Transcription Termination
journal, May 1995


Genetic diversity of the human immunoglobulin heavy chain VH region
journal, December 2002


Proteomics to study genes and genomes
journal, June 2000


Reconstitution of B Cell Antigen Receptor-induced Signaling Events in a Nonlymphoid Cell Line by Expressing the Syk Protein-tyrosine Kinase
journal, March 1996